SGCB and chronic kidney disease: Vericiguat, a soluble guanylate cyclase (sGC) stimulator, has established cardioprotective effects, but its potential renoprotective role and underlying mechanisms in CsA-induced CKD remain unexplored.<h4>Methods</h4>An integrative approach was employed.